$4.71
-0.17[-3.48%]
At close: Apr 26
$4.71
0[0.00%]
After Hours: 8:17AM EDT
Affimed
(NASDAQ:AFMD)Latest News for Affimed Stock (NASDAQ:AFMD)
Affimed Stock (NASDAQ: AFMD)
Categories: All
Wednesday, April 24, 2024
Monday, April 01, 2024
- Affirmed shares are trading higher after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $10.Benzinga Newsdesk - Apr 1, 2024, 1:51PM
- Wells Fargo Maintains Overweight on Affimed, Lowers Price Target to $25Benzinga Newsdesk - Apr 1, 2024, 11:37AM
- Cantor Fitzgerald Reiterates Overweight on AffimedBenzinga Newsdesk - Apr 1, 2024, 11:15AM
- HC Wainwright & Co. Maintains Buy on Affimed, Raises Price Target to $10Benzinga Newsdesk - Apr 1, 2024, 6:36AM
Thursday, March 28, 2024
- Affimed Q4 EPS $(1.50) Beats $(1.67) Estimate, Sales $444.55K Miss $1.70M EstimateBenzinga Newsdesk - Mar 28, 2024, 8:25AM
- Affimed FY2023 EPS €(7.09) Down From €(6.04) YoY, Sales €8.91M Down From €41.35M YoY; Cash, Cash Equivalents And Investments Of €72M Provide Cash Runway Into 2H 2025Benzinga Newsdesk - Mar 28, 2024, 6:43AM
- Earnings Scheduled For March 28, 2024Benzinga Insights - Mar 28, 2024, 5:24AM
Wednesday, March 27, 2024
Monday, March 11, 2024
Friday, March 08, 2024
Wednesday, March 06, 2024
- Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Mar 6, 2024, 1:54PM
- Affimed shares are trading lower after the company announced a 1-for-10 reverse stock split.Benzinga Newsdesk - Mar 6, 2024, 7:37AM
- Affimed Announces 1-for-10 Reverse Stock SplitBenzinga Newsdesk - Mar 6, 2024, 6:41AM
Monday, January 08, 2024
- Affimed Provides Clinical Response Update On AFM24-102 Trial In EGFR-Wildtype Non-Small Cell Lung CancerBenzinga Newsdesk - Jan 8, 2024, 4:16PM
- Affimed Confirms Guidance On Data Readouts For AFM24-102 And LuminICE-203 In H1 2024Benzinga Newsdesk - Jan 8, 2024, 8:29AM
- Affimed Announces Leadership Change And Organizational Restructuring; Dr. Adi Hoess To Step Down As CEO And Management Board Member; Dr. Andreas Harstrick Appointed Interim CEO; Strategic Restructuring Reducing Headcount By Up To 50%Benzinga Newsdesk - Jan 8, 2024, 8:29AM
Thursday, January 04, 2024
Wednesday, January 03, 2024
Monday, December 11, 2023
- Affimed Announces Data for AFM24 in Combination With Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer PatientsBenzinga Newsdesk - Dec 11, 2023, 6:03AM
- Affimed Announced Updated Data On Its Lead Innate Cell Engager Acimtamig In Combination With Allogeneic NK In Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy And Are Double-refractory To Brentuximab Vedotin And Checkpoint InhibitorsBenzinga Newsdesk - Dec 11, 2023, 6:02AM
Wednesday, November 15, 2023
Tuesday, November 14, 2023
- Earnings Scheduled For November 14, 2023Benzinga Insights - Nov 14, 2023, 8:23AM
- Affimed's Cash, Cash Equivalents And Financial Assets Of €97.5M Is expected To Provide Cash Runway Into 2025Benzinga Newsdesk - Nov 14, 2023, 6:35AM
- Recap: Affimed Q3 EarningsBenzinga Insights - Nov 14, 2023, 6:35AM
- Affimed Q3 EPS $(0.17) Beats $(0.20) Estimate, Sales $2.14M Beat $2.01M EstimateBenzinga Newsdesk - Nov 14, 2023, 6:34AM
Monday, November 13, 2023
Monday, November 06, 2023
Thursday, November 02, 2023
Wednesday, October 04, 2023
Wednesday, September 27, 2023
Monday, September 25, 2023
Tuesday, September 12, 2023
- Cantor Fitzgerald Reiterates Overweight on Affimed, Maintains $7 Price TargetBenzinga Newsdesk - Sep 12, 2023, 9:00AM
- Affimed Wins FDA Fast Track Designation for AFM13 in Combination with AlloNK for the Treatment of Patients with Relapsed or Refractory Hodgkin LymphomaBenzinga Newsdesk - Sep 12, 2023, 6:32AM
Thursday, September 07, 2023
Tuesday, August 22, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
- Earnings Scheduled For August 10, 2023Benzinga Insights - Aug 10, 2023, 6:59AM
- Affimed's Q2 Cash And Cash Equivalents Of €120.1M Is Expected To Support Operations Into 2025Benzinga Newsdesk - Aug 10, 2023, 6:37AM
- Affimed Q2 EPS $(0.22) Misses $(0.21) Estimate, Sales $1.52 Miss $4.53M EstimateBenzinga Newsdesk - Aug 10, 2023, 6:35AM